Meperidine Distribution Trends
Cross-source consensus on Meperidine Distribution Trends from 1 sources and 6 claims.
1 sources · 6 claims
How it works
Comparisons
Evidence quality
Other
Highlighted claims
- Total US meperidine distribution fell from 292,694,240 mg in 2019 to 123,433,330 mg in 2023, a reduction of 57.8%. — Patterns in meperidine distribution and associations with income and obesity in the USA and Puerto Rico between 2019 and 2023: a retrospective study
- On a per-capita basis, mean meperidine distribution declined 62.2% and the median declined 68.3% between 2019 and 2023. — Patterns in meperidine distribution and associations with income and obesity in the USA and Puerto Rico between 2019 and 2023: a retrospective study
- The overwhelming majority — 48.3 percentage points — of the total meperidine reduction occurred between 2019 and 2020 alone. — Patterns in meperidine distribution and associations with income and obesity in the USA and Puerto Rico between 2019 and 2023: a retrospective study
- Post-2020 stagnation in meperidine decline is a novel and concerning finding, as prior research documented a fairly uniform decline from 2000 to 2019. — Patterns in meperidine distribution and associations with income and obesity in the USA and Puerto Rico between 2019 and 2023: a retrospective study
- Data for the first half of 2024 confirmed that the downward trend in meperidine distribution continues at a modest pace with geographic patterns unchanged. — Patterns in meperidine distribution and associations with income and obesity in the USA and Puerto Rico between 2019 and 2023: a retrospective study
- Possible contributors to the post-2020 plateau include disruption of opioid stewardship programs during the COVID-19 pandemic, formulary inertia, and cost pressures. — Patterns in meperidine distribution and associations with income and obesity in the USA and Puerto Rico between 2019 and 2023: a retrospective study